Related Experiment Videos
Genomic profiling. Interplay between clinical epidemiology, bioinformatics and biostatistics
1IBE, Biometry and Bioinformatics, University of Munich, Munich, Germany. mansmann@ibe.med.uni-muenchen.de
Methods of Information in Medicine
|August 23, 2005
Summary
Evaluating genomic profiling studies for breast cancer prognosis is crucial. This review highlights methodological flaws and offers principles for designing robust future studies to ensure reliable prognostic signatures.
Area of Science:
- Genomics
- Biostatistics
- Oncology
Background:
- Microarray-based prognostic profiling lacks standardized evaluation methods.
- Unaddressed questions concern study assessment, conclusion validity, and flaw detection.
- Methodological imperfections risk resource waste and erroneous findings.
Purpose of the Study:
- To critically evaluate the methodological quality of seminal breast cancer genomic profiling studies.
- To identify common pitfalls in the design and execution of prognostic profiling research.
- To propose a strategy and principles for improving the design of future genomic profiling studies.
Main Methods:
- Analysis of three key breast cancer genomic profiling papers.
- Application of six core principles of experimental design for evaluation: relevant endpoints, bias avoidance, generalizability, sample size/power, design simplicity, and assumption avoidance.
Main Results:
- All three reviewed papers exhibited significant violations of at least one core experimental design principle.
- A systematic strategy is proposed for assessing the methodological rigor of profiling studies.
- The presented strategy aids in establishing protocols for future genomic profiling projects.
Conclusions:
- Establishing a study protocol is essential for navigating the complexities of genomic profiling.
- Adherence to basic guiding principles is vital for designing effective prognostic studies.
- Implementing robust design principles can help identify reliable genomic signatures for cancer prognosis.